Phase Ib Pharmacodynamic Study of the MNK Inhibitor Tomivosertib (eFT508) Combined With Paclitaxel in Patients With Refractory Metastatic Breast Cancer
2024 · Clinical Cancer Research · 5 citations
https://doi.org/10.1158/1078-0432.ccr-24-0841
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
304
Citations
8
h-index
8
i10-index
Sam Sperry is an academic researcher. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Advanced Breast Cancer Therapies & Microbial Natural Products and Biosynthesis. The author has an h-index of 8, co-authored 28 publications.
https://doi.org/10.1158/1078-0432.ccr-24-0841
https://doi.org/10.1158/1078-0432.28332736
Click to start Chat